Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Healthcare
Create a narrative
Smith & Nephew Community
LSE:SN. Community
1
Narratives
written by author
0
Comments
on narratives written by author
47
Fair Values set
on narratives written by author
Create a narrative
Smith & Nephew
Popular
Undervalued
Overvalued
Community Investing Ideas
Smith & Nephew
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Restructuring Will Improve Operating Efficiency By 2025
Key Takeaways Strategic restructuring and innovative platforms like CORI and REGENETEN are enhancing revenue growth and operational efficiency, impacting margins positively as macroeconomic conditions stabilize. Advanced Wound Management and Sports Medicine segments' growth through innovation is expected to improve market share, product mix, and overall earnings.
View narrative
UK£12.12
FV
10.9% undervalued
intrinsic discount
4.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
31
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
SN.
SN.
Smith & Nephew
Your Fair Value
UK£
Current Price
UK£10.81
61.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
7b
2015
2018
2021
2024
2025
2027
2030
Revenue US$7.4b
Earnings US$523.7m
Advanced
Set Fair Value